Drug recall · May 26, 2021
Hydrocodone Bitartrate and Homatropine Methlybromide tablets recall
Why: Failed Impurities/Degradation Specifications
Class III: unlikely to cause harm, but breaks the rules (for example a labeling error).
The recall
- Product
Hydrocodone Bitartrate and Homatropine Methlybromide tablets, USP, 5 mg/ 1.5 mg, 30-count bottle, Rx only, Mfd. By:KVK-Tech, Inc., Newtown, PA, 18940 NDC 10702-055-03
- Lots / codes
Lot: 15684A, Exp 7/2021
- Quantity
- 17,096 bottles
- Company
- KVK-Tech, Inc., Newtown, PA
- Distribution
- Distributed Nationwide in the USA
- Initiated
- April 27, 2021 · Voluntary: Firm initiated
- Classified
- May 17, 2021
- Reported
- May 26, 2021
- Ended
- October 5, 2022
- How notified
- Letter
The drug: prices, other makers, shortages
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.
Watch Homatropine / hydrocodone
One email when the price moves, a recall or shortage is posted, or the label changes. Plus the monthly biggest-movers report. Unsubscribe in one click.